Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

2.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
2.3K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

528
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
528

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heparin-Binding Proteins in the Nanoparticle Corona Enhance Cellular Uptake through Glycocalyx Interactions.

ACS nano·2025
Same author

Glycocalyx Interactions Modulate the Cellular Uptake of Albumin-Coated Nanoparticles.

ACS applied bio materials·2024
Same author

Realizing active targeting in cancer nanomedicine with ultrasmall nanoparticles.

Beilstein journal of nanotechnology·2024
Same author

Flotation Coefficient Distributions of Lipid Nanoparticles by Sedimentation Velocity Analytical Ultracentrifugation.

ACS nano·2024
Same author

Stealth and Biocompatible Gold Nanoparticles through Surface Coating with a Zwitterionic Derivative of Glutathione.

Langmuir : the ACS journal of surfaces and colloids·2024
Same author

A fluorescent quantum dot conjugate to probe the interaction of Enterolobium contortisiliquum trypsin inhibitor with cancer cells.

International journal of biological macromolecules·2023

Related Experiment Video

Updated: May 7, 2025

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
06:27

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Published on: November 30, 2018

9.1K

How Dendrimers Impact Fibrin Clot Formation, Structure, and Properties.

Natasha Mina1, Vinicius S Guido1, Benedito C Prezoto2

  • 1Department of Biochemistry, Federal University of São Paulo, São Paulo, SP 04044-020, Brazil.

ACS Omega
|January 6, 2025
PubMed
Summary

Low-generation polyamidoamine (PAMAM) dendrimers impact blood clotting. While some PAMAM dendrimers like G2-NH2 and G4-NH2 disrupt hemostasis, G3.5-COOH shows potential for safe biomedical use.

More Related Videos

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.4K
Preparation of 3D Fibrin Scaffolds for Stem Cell Culture Applications
07:04

Preparation of 3D Fibrin Scaffolds for Stem Cell Culture Applications

Published on: March 2, 2012

25.1K

Related Experiment Videos

Last Updated: May 7, 2025

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
06:27

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Published on: November 30, 2018

9.1K
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.4K
Preparation of 3D Fibrin Scaffolds for Stem Cell Culture Applications
07:04

Preparation of 3D Fibrin Scaffolds for Stem Cell Culture Applications

Published on: March 2, 2012

25.1K

Area of Science:

  • Nanomedicine
  • Biomaterials Science
  • Hemostasis Research

Background:

  • Polyamidoamine (PAMAM) dendrimers offer versatile biomedical applications due to their unique structure.
  • Concerns exist regarding in vivo interactions of PAMAM dendrimers with blood components, potentially affecting hemostasis.
  • Understanding these interactions is crucial for safe clinical translation of dendrimer-based therapies.

Purpose of the Study:

  • To investigate the effects of low-generation PAMAM dendrimers on fibrin clot formation kinetics.
  • To evaluate the influence of different PAMAM dendrimer types on clot structure, properties, and lysis resistance.
  • To identify PAMAM dendrimer characteristics associated with safe hemostatic profiles.

Main Methods:

  • Utilized a multilevel characterization approach with purified fibrinogen, human plasma, and whole blood.
  • Assessed the impact of four PAMAM dendrimer types: G2-NH2, G4-NH2, G3.5-COOH, and G4-OH.
  • Analyzed thrombin generation, clot formation time, fibrin aggregation, clot permeability, and clot lysis.

Main Results:

  • G2-NH2 and G4-NH2 dendrimers significantly impaired thrombin generation and delayed clot formation.
  • G4-NH2 also promoted fibrin aggregation, increased clot permeability, and accelerated lysis.
  • G4-OH at high concentrations delayed thrombin generation and prolonged clotting time in plasma and whole blood.
  • G3.5-COOH demonstrated minimal alterations in clotting parameters, suggesting a safer profile.

Conclusions:

  • Specific PAMAM dendrimer structures (G2-NH2, G4-NH2, G4-OH) can adversely affect hemostasis.
  • G3.5-COOH emerges as a potentially safer dendrimer for biomedical applications due to its limited impact on clotting.
  • These findings are vital for the rational design and safe concentration determination of PAMAM dendrimers in clinical settings.